RVLP RVL Pharmaceuticals plc

RVL Pharmaceuticals PLC is a fully-integrated biopharmaceutical company. It is focused on developing, manufacturing, and commercializing specialty products.

$1.41  +0.05 (3.68%)
As of 07/01/2022 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  10/19/2018
Outstanding shares:  83,549,659
Average volume:  97,259
Market cap:   $113,627,536
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   -1.90
PB ratio:   1.69
PS ratio:   2.99
Return on equity:   -89.42%
Net income %:   -163.45%